Evonik has made the strategic decision to launch its own guanidinoacetic acid-product (GAA) used to enhance energy metabolism in livestock production. The market launch is planned as soon as possible and became necessary after Trostberg-based, AlzChem Group AG terminated its supply agreement with Evonik as of 31.12.2018. The GAA product CreAMINO® currently distributed by Evonik is manufactured by AlzChem.
Evonik will continue to supply its customers until at least the end of 2018. The termination of the contract with AlzChem AG will open options for Evonik to further develop the use of GAA in animal nutrition and to supply the global market with its own GAA product.
“With our comprehensive animal nutrition expertise and our broad portfolio of feed additives, we are the perfect partner for the use of GAA in modern feeding concepts,” says Dr Emmanuel Auer, Head of the Animal Nutrition Business Line at Evonik. “The product is an important element in healthy, efficient and sustainable animal nutrition. That's why we are working hard on a new solution and are pleased to take full ownership of GAA production.”
Guanidinoacetic acid is an essential component for the organism in building creatine and it also serves as a key source of arginine. Creatine is vital for vertebrates as it contributes to ensuring that the muscle cells are supplied with energy. With the addition of GAA to animal feed, the feed conversion in livestock production can be improved.